Last reviewed · How we verify

NCT06345430

Wearable Technological Device Applied to Patients with Chronic Pain

Completed NA Last updated 20 January 2025
What this trial tests

NA trial testing Exopulse Molli-Suit (Wearable Technological Device) in Neck Pain in 40 participants. Completed in 30 June 2024.

Timeline
18 December 2023
Primary endpoint
15 April 2024
30 June 2024

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date18 December 2023
Primary completion15 April 2024
Estimated completion30 June 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 20 to 65, any sex, with Neck Pain or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Within the scope of this research, a single session of Wearable Technological Device (Exopulse Molli-Suit) will be applied to patients with chronic back and neck pain. The results will be evaluated acutely, after 24 hours, after 1 week and after 1 month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06345430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing